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Supplementary Materials  
Supplementary Information S1: Sample size and power calculations 
The conventional thresholds of α=5% (significance level) and β=20% (1-power; power of 80%) were 
applied for sample size calculation using the statistics programs MedCalc 19.0.6 (MedCalc Software 
bvba, Ostend, Belgium), GPower 3.1.9.4 (Franz Faul; Kiel University, Kiel, Germany), and GraphPad 
StatMate 2.0 (GraphPad Software, San Diego, CA, USA). 
Receiver-operating characteristics (ROC) analysis was performed to calculate the necessary sample 
size to evaluate the capacity of the different miRNAs to discriminate between matched pairs of 
malignant and adjacent normal tissue. According to previous studies, we defined as appropriate 
discrimination an area under the ROC curve higher than 0.75. A sample size of at least 19 pairs would 
be necessary.  
The necessary sample size was calculated for assessing the usefulness of variables/markers for the 
clinical prognostic endpoint of biochemical recurrence (BCR). Assuming a difference of 0.20 in the 
Kaplan-Meier "survival" rate within five-year follow-up after radical prostatectomy and selecting tissue 
samples in this retrospective study by an alternate selection process of patients with (assuming a rate of 
0.70) and without BCR (assuming a rate of 0.90) in a consecutive manner resulting in a ratio of one, a 
total sample size of at least 67 would be required. 
 
Table S1. TaqMan MicroRNA assays used for RT-qPCR analyses Assay names and assay IDs are taken from the nomenclature of the supplier Thermo Fisher. The miRBase 
















miRNA Gene Family Clustered miRNAs 
hsa-miR-1-3p MIMAT0000416 hsa-miR-1 002222 
UGGAAUGUAAAGA
AGUAUGUAU 
Chr. 18: 21829004 - 
21829088 [-] 
mir-1 (mir-1-1, mir-1-2, mir-
206) 
mir-133a-1 
hsa-miR-21-5p MIMAT0000076 hsa-miR-21 000397 
UAGCUUAUCAGAC
UGAUGUUGA 
Chr. 17: 59841266 - 
59841337 [+] 
mir-21 – 
hsa-miR-29c-3p  MIMAT0000681 hsa-miR-29c 000587 
UAGCACCAUUUGA
AAUCGGUUA 
Chr. 1: 207801852 - 
207801939 [-] 
mir-29 (mir-29a, mir-29b-1, 
mir-29b-2,mir-29c) 
mir-29b-2 
hsa-miR-30c-5p MIMAT0000244 hsa-miR-30c 000419 
UGUAAACAUCCUAC
ACUCUCAGC 
Chr. 1: 40757284 - 
40757372 [+] 




hsa-miR-30d-5p MIMAT0000245 hsa-miR-30d 000420 
UGUAAACAUCCCCG
ACUGGAAG 
Chr. 8: 134804876 - 
134804945 [-] 




hsa-miR-31-5p  MIMAT0000089 hsa-miR-31 002279 
AGGCAAGAUGCUG
GCAUAGCU 
Chr. 9: 21512115 - 
21512185 [-] 
mir-31  – 
hsa-miR-34a-5p MIMAT0000255 hsa-miR-34a 000426 
UGGCAGUGUCUUA
GCUGGUUGU 
Chr. 1: 9151668 -9151777 
[-] 
mir-34 (mir-34a, mir-34b, 
mir-34c) 
– 
hsa-miR-141-3p  MIMAT0000432 hsa-miR-141 000463 
UAACACUGUCUGG
UAAAGAUGG 
Chr.12: 6964097 - 6964191 
[+] 
mir-8 (mir-141, mir-200a, 
mir-200b, mir-200c, mir-429) 
mir-200c 
hsa-miR-145-5p MIMAT0000437 hsa-miR-145 002278 
GUCCAGUUUUCCCA
GGAAUCCCU 
Chr. 5: 149430646 - 
149430733 [+] 







Chr. 7: 25949919 - 
25949986 [-] 
mir-148 (mir-148a, mir-148b, 
mir-152) 
– 
hsa-miR-185-5p MIMAT0000455 hsa-miR-185 002271 
UGGAGAGAAAGGC
AGUUCCUGA 
Chr. 22: 20033139 - 
20033220 [+] 
mir-185 – 
hsa-miR-195-5p MIMAT0000461 hsa-miR-195 000494 
UAGCAGCACAGAA
AUAUUGGC 
Chr. 17: 7017615 - 
7017701 [-] 
mir-15 (mir-15a, mir-15b, 
mir-16-1, mir-16-2, mir-195) 
mir-497 
hsa-miR-204-5p MIMAT0000265 hsa-miR-204 000508 
UUCCCUUUGUCAUC
CUAUGCCU 
Chr. 9: 70809975 - 
70810084 [-] 















miRNA Gene Family Clustered miRNAs 
hsa-miR-221-3p MIMAT0000278 hsa-miR-221 000524 
AGCUACAUUGUCU
GCUGGGUUUC 
Chr. X: 45746157 - 
45746266 [-] 
mir-221 (mir-221, mir-222) mir-222 
hsa-miR-224-5p + MIMAT0000281 hsa-miR-224 002099 
UCAAGUCACUAGU
GGUUCCGUUUAG 
Chr. X: 151958578 -
151958658 [-] 
mir-224 mir-452 
hsa-miR-301a-3p MIMAT0000688 hsa-miR-301 000528 
CAGUGCAAUAGUA
UUGUCAAAGC 
Chr. 17: 59151136 - 
59151221 [-] 
mir-130 (mir-130a, mir-130b, 
mir-301a, mir-301b) 
– 
hsa-miR-326 MIMAT0000756 hsa-miR-326 000542 
CCUCUGGGCCCUUC
CUCCAG 









Chr. X: 74218547 - 
74218618 [-] 
mir-374 (mir-374a, mir-374b, 
mir-374c) 
– 
hsa-miR-494-3p  MIMAT0002816 hsa-miR-494 002365 
UGAAACAUACACG
GGAAACCUC 
Chr. 14: 101029634 - 
101029714 [+] 
mir-154 (mir-154, mir-300, 
mir-323a, mir-323b, mir-369, 
mir-377, mir-381, mir-382, 
mir-409, mir-410, mir-487a, 
mir-487b, mir-494, mir-496, 









hsa-miR-939-5p  MIMAT0004982 hsa-miR-939 002182 
UGGGGAGCUGAGG
CUCUGGGGGUG 
Chr. 8: 144394149 - 
144394230 [-] 
mir-939 mir-1234, mir-6849 
Reference-miRNAs       
hsa-let-7g-5p  MIMAT0000414 hsa-let-7g 002282 
UGAGGUAGUAGUU
UGUACAGUU 
Chr. 3: 52268278 -
52268361 [-] 
let7 (let-7a-1, let-7a-2, let-7a-
3, let-7b, let-7c, let-7d, let-7e, 
let-7f-1, let-7f-2, mir-98, let-
7g, let-7i) 
– 
hsa-miR-103a-3p  MIMAT0000101 hsa-miR-103 000439 
AGCAGCAUUGUAC
AGGGCUAUGA 






+ Until miRBase 21; however, this miRNA has now the miRBase ID eca-miR-224 (accession no. MIMAT0013206). 
Table S2. MicroRNAs in tumor samples in relationship to the digital rectal examination result. 
Variable 
DRE = non-suspicious DRE = suspicious   
n Median Average Rank n Median Average Rank p value a 
miR-1-3p 122 1.0850 109.3934 84 0.8950 94.9405 0.087 
miR-21-5p 122 0.9700 97.0041 84 1.0850 112.9345 0.059 
miR-29c-3p 122 0.9900 105.2049 84 0.8500 101.0238 0.621 
miR-30c-5p 122 1.0650 109.7828 84 0.9750 94.3750 0.068 
miR-30d-5p 122 0.9450 102.4672 84 0.9900 105.0000 0.764 
miR-31-5p 122 1.3800 106.1352 84 1.0550 99.6726 0.445 
miR-34a-5p 122 0.9650 105.0369 84 0.9200 101.2679 0.656 
miR-141-3p 122 1.0300 104.5697 84 0.9750 101.9464 0.756 
miR-145-5p 122 1.0250 106.5615 84 0.9700 99.0536 0.374 
miR-148a-3p 122 1.0350 103.2623 84 0.9700 103.8452 0.945 
miR-185-5p 122 0.9750 102.8893 84 0.9550 104.3869 0.859 
miR-195-5p 122 1.0450 101.8525 84 1.1000 105.8929 0.633 
miR-204-5p 122 1.0550 106.5779 84 0.9200 99.0298 0.372 
miR-221-3p 122 0.7950 107.5246 84 0.6950 97.6548 0.243 
miR-224-5p 122 0.9050 105.3730 84 0.8850 100.7798 0.587 
miR-301a-3p 122 1.0500 103.4549 84 1.0200 103.5655 0.990 
miR-326 122 1.0100 103.5246 84 1.0050 103.4643 0.994 
miR-374b-5p 122 1.0750 105.1557 84 1.0200 101.0952 0.631 
miR-494-3p 122 0.8050 100.0000 84 0.8300 108.5833 0.310 
miR-939-5p 122 0.9850 103.6475 84 1.0300 103.2857 0.966 
Abbreviations: DRE, digital rectal examination, 0=non-suspicious, 1=suspicious. a Mann-Whitney test. 
  
Table S3. MicroRNAs in tumor samples in relationship to the margin status. 
Variable 
pN status = negative pN status = positive  
n Median Average Rank n Median Average Rank p-value a 
miR-1-3p 196 1.0500 104.9770 10 0.6550 74.5500 0.115 
miR-21-5p 196 1.0150 103.2041 10 1.1900 109.3000 0.752 
miR-29c-3p 196 0.9800 105.4796 10 0.6100 64.7000 0.035 
miR-30c-5p 196 1.0250 105.1403 10 0.8100 71.3500 0.080 
miR-30d-5p 196 0.9900 104.7194 10 0.7200 79.6000 0.194 
miR-31-5p 196 1.3300 105.2372 10 0.2750 69.4500 0.064 
miR-34a-5p 196 0.9500 105.4107 10 0.6750 66.0500 0.042 
miR-141-3p 196 1.0150 104.1224 10 0.8950 91.3000 0.507 
miR-145-5p 196 0.9900 104.9821 10 0.6650 74.4500 0.114 
miR-148a-3p 196 1.0150 103.4362 10 1.0000 104.7500 0.946 
miR-185-5p 196 0.9650 103.7704 10 1.0750 98.2000 0.773 
miR-195-5p 196 1.0700 103.0842 10 1.2300 111.6500 0.658 
miR-204-5p 196 1.0300 104.9745 10 0.8200 74.6000 0.116 
miR-221-3p 196 0.7500 104.1403 10 0.7050 90.9500 0.495 
miR-224-5p 196 0.8950 104.9184 10 0.5700 75.7000 0.131 
miR-301a-3p 196 1.0350 103.0485 10 1.1800 112.3500 0.630 
miR-326 196 1.0100 104.5689 10 0.8300 82.5500 0.255 
miR-374b-5p 196 1.0600 104.8010 10 0.8000 78.0000 0.166 
miR-494-3p 196 0.8050 103.9158 10 0.8750 95.3500 0.658 
miR-939-5p 196 1.0250 105.2500 10 0.6750 69.2000 0.062 
Abbreviations: pN status, lymph node status. a Mann-Whitney test, significant values (p <0.050) are 
highlighted in yellow. 
Table S4. MicroRNAs in tumor samples in relationship to the lymph node status. 
Variable 
pN status = negative pN status = positive   
n Median Average Rank n Median Average Rank p-value a 
miR-1-3p 196 1.0500 104.9770 10 0.6550 74.5500 0.115 
miR-21-5p 196 1.0150 103.2041 10 1.1900 109.3000 0.752 
miR-29c-3p 196 0.9800 105.4796 10 0.6100 64.7000 0.035 
miR-30c-5p 196 1.0250 105.1403 10 0.8100 71.3500 0.080 
miR-30d-5p 196 0.9900 104.7194 10 0.7200 79.6000 0.194 
miR-31-5p 196 1.3300 105.2372 10 0.2750 69.4500 0.064 
miR-34a-5p 196 0.9500 105.4107 10 0.6750 66.0500 0.042 
miR-141-3p 196 1.0150 104.1224 10 0.8950 91.3000 0.507 
miR-145-5p 196 0.9900 104.9821 10 0.6650 74.4500 0.114 
miR-148a-3p 196 1.0150 103.4362 10 1.0000 104.7500 0.946 
miR-185-5p 196 0.9650 103.7704 10 1.0750 98.2000 0.773 
miR-195-5p 196 1.0700 103.0842 10 1.2300 111.6500 0.658 
miR-204-5p 196 1.0300 104.9745 10 0.8200 74.6000 0.116 
miR-221-3p 196 0.7500 104.1403 10 0.7050 90.9500 0.495 
miR-224-5p 196 0.8950 104.9184 10 0.5700 75.7000 0.131 
miR-301a-3p 196 1.0350 103.0485 10 1.1800 112.3500 0.630 
miR-326 196 1.0100 104.5689 10 0.8300 82.5500 0.255 
miR-374b-5p 196 1.0600 104.8010 10 0.8000 78.0000 0.166 
miR-494-3p 196 0.8050 103.9158 10 0.8750 95.3500 0.658 
miR-939-5p 196 1.0250 105.2500 10 0.6750 69.2000 0.062 
Abbreviations: pN status, lymph node status. a Mann-Whitney test, significant values (p <0.050) are 
highlighted in yellow. 
Table S5. Associations between clinicopathological variables and microRNAs in the examined tumor 
samples. The relationships are indicated as p-values calculated by Spearman rank correlation 
coefficients, Mann-Whitney test or Kruskal-Wallis test. 
miRNA Age a PSA a DRE b Margin b pN status b pT stage c ISUP c 
miR-1-3p 0.557 0.001↓ 0.087 0.037↓ 0.115 0.035 <0.0001 
miR-21-5p 0.214 0.922 0.059 0.065 0.752 0.259 0.014 
miR-29c-3p 0.139 0.668 0.621 0.424 0.035↓ 0.970 0.047 
miR-30c-5p 0.901 0.125 0.068 0.047↓ 0.080 0.134 0.642 
miR-30d-5p 0.294 0.783 0.764 0.357 0.194 0.852 0.095 
miR-31-5p 0.178 0.220 0.445 0.005↓ 0.064 0.770 0.001 
miR-34a-5p 0.318 0.090 0.656 0.102 0.042↓ 0.261 0.170 
miR-141-3p 0.174 0.025↑ 0.756 0.108 0.507 0.224 0.001 
miR-145-5p 0.604 0.002↓ 0.374 0.009↓ 0.114 0.098 0.001 
miR-148a-3p 0.546 0.334 0.945 0.009↑ 0.946 0.383 0.001 
miR-185-5p 0.976 0.371 0.859 0.168 0.773 0.505 0.481 
miR-195-5p 0.870 0.050↓ 0.633 0.002↓ 0.658 0.350 0.799 
miR-204-5p 0.090 0.002↓ 0.372 0.076 0.116 0.562 0.002 
miR-221-3p 0.983 0.253 0.243 0.651 0.495 0.127 0.004 
miR-224-5p 0.208 0.049↓ 0.587 0.012↓ 0.131 0.186 0.102 
miR-301a-3p 0.528 0.670 0.990 0.253 0.630 0.254 0.441 
miR-326 0.517 0.495 0.994 0.186 0.255 0.912 0.138 
miR-374b-5p 0.611 0.367 0.631 0.168 0.166 0.826 0.713 
miR-494-3p 0.584 0.945 0.310 0.069 0.658 0.287 0.438 
miR-939-5p 0.999 0.702 0.966 0.671 0.062 0.088 0.031 
Abbreviations: miRNA, human microRNAs, see Table 2; PSA, prostate specific antigen; DRE, digital 
rectal examination result, positive/negative; pN status, pathological lymph node status, 
positive/negative; pT stage, pathological tumor classification, see Table 1; ISUP, histopathological grade 
system based on Gleason score according to the International Society of Urologic Pathology, see Table 1. 
a, b, c p values highlighted in yellow (a Spearman rank for age and PSA; b Mann-Whitney test for DRE, 
margin, and pN status; c Kruskal-Wallis test for pT stage and ISUP grade groups) indicate significant 
associations between clinicopathological variables and corresponding miRNAs, details are shown in 
Tables S2 to S4 and Figures S2 and S3. The arrows indicate positive↑/negative ↓ correlations/associations. 
The relationships between pT stages and ISUP grades are shown in the Figures S2 and S3. 
  
Table S6. Spearman rank correlation coefficients among the microRNAs analyzed in tumor samples. 
Significant coefficients (p<0.05) are highlighted in yellow, coefficients >0.5 are highlighted in green. 
A) miR-1 to miR-148a 











miR-1 rs   0.227 0.175 0.420 0.232 0.222 0.358 -0.242 0.856 -0.162 
  p 
value 
  0.001 0.012 <0.0001 0.001 0.002 <0.0001 0.001 <0.0001 0.021 
miR-21 rs 0.227   0.470 0.324 0.429 0.279 0.567 0.311 0.319 0.302 
  p 
value 
0.001   <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
miR-29c rs 0.175 0.470   0.519 0.585 0.027 0.533 0.649 0.254 0.623 
  p 
value 
0.012 <0.0001   <0.0001 <0.0001 0.698 <0.0001 <0.0001 0.0002 <0.0001 
miR-30c rs 0.420 0.324 0.519   0.713 0.087 0.526 0.287 0.489 0.310 
  p 
value 
<0.0001 <0.0001 <0.0001   <0.0001 0.213 <0.0001 <0.0001 <0.0001 <0.0001 
miR-
30d rs 0.232 0.429 0.585 0.713   0.033 0.509 0.416 0.328 0.425 
  p 
value 
0.001 <0.0001 <0.0001 <0.0001   0.634 <0.0001 <0.0001 <0.0001 <0.0001 
miR-31 rs 0.222 0.279 0.027 0.087 0.033   0.209 -0.069 0.230 -0.162 
  p 
value 
0.002 <0.0001 0.698 0.213 0.634   0.003 0.326 0.001 0.020 
miR-34a rs 0.358 0.567 0.533 0.526 0.509 0.209   0.307 0.526 0.314 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.003   <0.0001 <0.0001 <0.0001 
miR-141 rs -0.242 0.311 0.649 0.287 0.416 -0.069 0.307   -0.137 0.752 
  p 
value 
0.001 <0.0001 <0.0001 <0.0001 <0.0001 0.326 <0.0001   0.050 <0.0001 
miR-145 rs 0.856 0.319 0.254 0.489 0.328 0.230 0.526 -0.137   -0.118 
  p 
value 
<0.0001 <0.0001 0.000 <0.0001 <0.0001 0.001 <0.0001 0.050   0.090 
miR-
148a rs -0.162 0.302 0.623 0.310 0.425 -0.162 0.314 0.752 -0.118   
  p 
value 
0.021 <0.0001 <0.0001 <0.0001 <0.0001 0.020 <0.0001 <0.0001 0.090   
miR-185 rs 0.282 0.652 0.469 0.540 0.639 0.118 0.648 0.274 0.397 0.215 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.092 <0.0001 0.0001 <0.0001 0.002 
miR-195 rs 0.385 0.480 0.295 0.616 0.553 0.089 0.435 -0.015 0.495 0.059 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.204 <0.0001 0.825 <0.0001 0.399 
miR-204 rs 0.579 0.161 0.126 0.322 0.164 0.154 0.461 -0.188 0.712 -0.197 
  p 
value 
<0.0001 0.021 0.072 <0.0001 0.018 0.028 <0.0001 0.007 <0.0001 0.005 
miR-221 rs 0.553 0.315 0.342 0.229 0.159 0.152 0.515 0.119 0.658 0.150 
  p 
value 
<0.0001 <0.0001 <0.0001 0.001 0.023 0.029 <0.0001 0.087 <0.0001 0.031 
miR-224 rs 0.548 0.338 0.146 0.236 0.105 0.578 0.376 -0.086 0.631 -0.145 
  p 
value 
<0.0001 <0.0001 0.037 0.001 0.135 <0.0001 <0.0001 0.220 <0.0001 0.038 
miR-
301a rs 0.479 0.418 0.228 0.537 0.475 -0.059 0.420 -0.103 0.517 0.037 
  p 
value 
<0.0001 <0.0001 0.001 <0.0001 <0.0001 0.401 <0.0001 0.139 <0.0001 0.595 
miR-326 rs 0.334 0.454 0.454 0.560 0.706 0.125 0.668 0.221 0.414 0.204 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.073 <0.0001 0.001 <0.0001 0.003 
miR-
374b rs 0.564 0.484 0.599 0.743 0.667 0.077 0.556 0.291 0.613 0.332 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.272 <0.0001 <0.0001 <0.0001 <0.0001 




0.003 0.003 0.005 0.217 0.064 0.348 0.010 0.032 0.002 0.007 
miR-939 rs 0.146 0.041 0.087 0.031 0.152 0.122 0.029 -0.031 0.066 0.029 
  p 
value 
0.038 0.559 0.214 0.660 0.029 0.080 0.679 0.659 0.343 0.675 
B) miR-185 to miR-939 



















miR-1 rs 0.282 0.385 0.579 0.553 0.548 0.479 0.334 0.564 0.208 0.146 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.003 0.038 
miR-21 rs 0.652 0.480 0.161 0.315 0.338 0.418 0.454 0.484 0.204 0.041 
  p 
value 
<0.0001 <0.0001 0.021 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.003 0.559 
miR-29c rs 0.469 0.295 0.126 0.342 0.146 0.228 0.454 0.599 0.194 0.087 
  p 
value 
<0.0001 <0.0001 0.072 <0.0001 0.037 0.001 <0.0001 <0.0001 0.005 0.214 
miR-30c rs 0.540 0.616 0.322 0.229 0.236 0.537 0.560 0.743 -0.086 0.031 
  p 
value 
<0.0001 <0.0001 <0.0001 0.001 0.001 <0.0001 <0.0001 <0.0001 0.217 0.660 
miR-
30d 
rs 0.639 0.553 0.164 0.159 0.105 0.475 0.706 0.667 0.129 0.152 
  p 
value 
<0.0001 <0.0001 0.018 0.023 0.135 <0.0001 <0.0001 <0.0001 0.064 0.029 
miR-31 rs 0.118 0.089 0.154 0.152 0.578 -0.059 0.125 0.077 -0.066 0.122 
  p 
value 
0.092 0.204 0.028 0.029 <0.0001 0.401 0.073 0.272 0.348 0.080 
miR-34a rs 0.648 0.435 0.461 0.515 0.376 0.420 0.668 0.556 0.180 0.029 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.010 0.679 
miR-141 rs 0.274 -0.015 -0.188 0.119 -0.086 -0.103 0.221 0.291 0.149 -0.031 
  p 
value 
0.0001 0.825 0.007 0.087 0.220 0.139 0.001 <0.0001 0.032 0.659 
miR-145 rs 0.397 0.495 0.712 0.658 0.631 0.517 0.414 0.613 0.219 0.066 
  p 
value 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.002 0.343 
miR-




0.002 0.399 0.005 0.031 0.038 0.595 0.003 <0.0001 0.007 0.675 
miR-185 rs   0.597 0.282 0.270 0.251 0.602 0.763 0.619 0.213 0.208 
  p 
value 
  <0.0001 <0.0001 0.0001 0.0003 <0.0001 <0.0001 <0.0001 0.002 0.003 
miR-195 rs 0.597   0.356 0.113 0.214 0.662 0.491 0.637 0.036 0.147 
  p 
value 
<0.0001   <0.0001 0.106 0.002 <0.0001 <0.0001 <0.0001 0.610 0.035 
miR-204 rs 0.282 0.356   0.503 0.441 0.381 0.298 0.348 0.189 0.060 
  p 
value 
<0.0001 <0.0001   <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.007 0.393 
miR-221 rs 0.270 0.113 0.503   0.544 0.290 0.277 0.375 0.272 -0.105 
  p 
value 
0.0001 0.106 <0.0001   <0.0001 <0.0001 0.0001 <0.0001 0.0001 0.135 
miR-224 rs 0.251 0.214 0.441 0.544   0.158 0.220 0.322 0.136 0.052 
  p 
value 
0.0003 0.002 <0.0001 <0.0001   0.023 0.002 <0.0001 0.052 0.458 
miR-




<0.0001 <0.0001 <0.0001 <0.0001 0.023   <0.0001 <0.0001 0.433 0.115 
miR-326 rs 0.763 0.491 0.298 0.277 0.220 0.564   0.632 0.224 0.265 
  p 
value 
<0.0001 <0.0001 <0.0001 0.0001 0.002 <0.0001   <0.0001 0.001 0.000 
miR-
374b 




<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001   0.006 0.023 
miR-494 rs 0.213 0.036 0.189 0.272 0.136 0.055 0.224 0.193   0.444 
  p 
value 
0.002 0.610 0.007 0.0001 0.052 0.433 0.001 0.006   <0.0001 
miR-939 rs 0.208 0.147 0.060 -0.105 0.052 0.110 0.265 0.158 0.444   
  p 
value 
0.003 0.035 0.393 0.135 0.458 0.115 0.0001 0.023 <0.0001   
Abbreviations: miR, microRNA in its abbreviated form to facilitate the readability of the table; full 
annotation in Table 2; rs, Spearman rank correlation coefficient. 
Table S7. Construction of a miRNA-based predictive classifier for biochemical recurrence using sample 
splitting approach. The 140 samples of the training set were randomly selected. The test set (n=66) was 
used to control the final model obtained with the training set (see Table 5). 
miRNA Univariate Cox Regression 
with a Training Set of n = 140  
Multivariate Cox Regression with Significant Univariate miRs a 
   Full model  Backward elimination 
 HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value 
miR-1-3p 0.67 (0.48 - 0.95) 0.026 0.92 (0.53-1.61) 0.774   
miR-21-5p 1.12 (1.01 - 1.24) 0.029 1.48 (0.85-2.59) 0.170   
miR-29c-3p 1.08 (0.81 - 1.45) 0.599     
miR-30c-5p 0.57 (0.31 - 1.06) 0.077 0.32 (0.12-0.86) 0.023 0.52 (0.28-0.96) 0.038 
miR-30d-5p 1.25 (1.08 - 1.44) 0.003 1.82 (1.07-3.09) 0.028   
miR-31-5p 0.75 (0.62 - 0.90) 0.002 0.76 (0.61-0.95) 0.017 0.71 (0.58-0.87) 0.001 
miR-34a-5p 1.12 (1.00 - 1.24) 0.043 0.55 (0.28-1.09) 0.087   
miR-141-3p 1.23 (1.08 - 1.42) 0.003 3.58 (1.66-7.70) 0.001 2.59 (1.90-4.60) <0.0001 
miR-145-5p 0.75 (0.54 - 1.05) 0.091 1.71 (0.85-3.43) 0.131   
miR-148a-3p 1.14 (0.97 - 1.34) 0.114 0.44 (0.23-0.87) 0.018 0.50 (0.34-0.74) <.0001 
miR-185-5p 1.06 (1.01 - 1.12) 0.019 0.83 (0.50-1.40) 0.489   
miR-195-5p 0.96 (0.66 - 1.39) 0.831     
miR-204-5p 0.83 (0.62 - 1.11) 0.204     
miR-221-3p 0.86 (0.69 - 1.07) 0.164 0.53 (0.32-0.88) 0.014 0.66 (0.52-0.85) 0.001 
miR-224-5p 0.71 (0.49 - 1.03) 0.072 0.80 (0.43-1.46) 0.457   
miR-301a-3p 0.91 (0.64 - 1.30) 0.609     
miR-326 1.03 (1.01 - 1.05) 0.007 1.01 (0.79-1.29) 0.918   
miR-374b-5p 0.91 (0.49 - 1.69) 0.770     
miR-494-3p 1.00 (1.00 - 1.01) 0.025 1.01 (0.97-1.04) 0.731   
miR-939-5p 1.02 (1.00 - 1.05) 0.022 0.92 (0.77-1.30) 0.999   
Abbreviations: HR, hazard ratio; CI, confidence interval. 
 
Table S8. C-statistics of three predictive BCR models based on only clinicopathological factors in 
comparison to 5-miR-panels and their combination. Data are given as ΔAUCs with p values in 
parentheses between the respective models of each group. Abbreviation: BCR, biochemical recurrence. 
Model D'Amico-Based Models CAPRAS-Based Model Full Model 
 Pure Combined Pure Combined Pure Combined 





























Figure S1. Expression of the 20 microRNAs analyzed in adjacent normal tissue samples (N; n=29) and 
all PCa tissue samples from patients with and without BCR (T; n=206). Normalized miRNA expression 
data are given as box- and whisker plots. Boxes represent the lower and upper quartiles with medians, 
whiskers illustrate the ranges of the miRNAs. Mann-Whitney U-test was performed. Abbreviations: Pca, 
prostate cancer; BCR, biochemical recurrence. 
 
Figure S2. Expression of the 20 microRNAs analyzed in PCa tissue samples categorized according to the 
pT stages. Expression data are given as medians with upper and lower quartiles. Significances are 
calculated by the Kruskal-Wallis test. Abbreviation: PCa, prostate cancer. 































































Figure S3. Expression of the 20 microRNAs analyzed in PCa tissue samples categorized according to the 
ISUP grades. Expression data are given as medians with upper and lower quartiles. Significances are 
































































































































Figure S4. ROC curve and decision curve analysis of the 5-miR-panel and the 6-miR-panel. Abbreviation: 
ROC, receiver operating characteristics. 
 
Figure S5. Stability of let-7g-5p and miR-103a-3p as suitability criterion for their use as normalizers. 
